LIGAND PHARMACEUTICALS INC
LGND
30 insider filings · Latest: Jun 16, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 1 8:57 PM | ANDREW REARDON | Proposed Sale | 10,000 | $316.09 | $3.2M | — | View → |
| Jun 16, 2026 | Jun 18 12:37 PM | Stephen L SabbaDirector | Sale | 2,145 | $254.00 | $544.8K | 33,629(D) | View → |
| Jun 16, 2026 | Jun 16 8:30 PM | STEPHEN L. SABBA | Proposed Sale | 2,145 | $254.00 | $544.8K | — | View → |
| Jun 12, 2026 | Jun 16 1:06 AM | Jason HaasDirector | Sale | 6,461 | $255.58 | $1.7M | 4,981(D) | View → |
| Jun 11, 2026 | Jun 12 9:27 PM | Jason AryehDirector | Sale | 4,500 | $250.00 | $1.1M | 102,580(D) | View → |
| Jun 10, 2026 | Jun 12 9:27 PM | Jason AryehDirector | Sale | 500 | $250.00 | $125.0K | 107,080(D) | View → |
| Jun 10, 2026 | Jun 12 9:26 PM | John L LamattinaDirector | Sale | 4,591 | $250.88 | $1.2M | 26,969(D) | View → |
| Jun 12, 2026 | Jun 12 8:09 PM | JASON HAAS | Proposed Sale | 6,461 | $256.00 | $1.7M | — | View → |
| Jun 11, 2026 | Jun 11 4:21 PM | Aryeh Jason | Proposed Sale | 4,500 | $249.97 | $1.1M | — | View → |
| Jun 10, 2026 | Jun 10 8:45 PM | Aryeh Jason | Proposed Sale | 500 | $249.96 | $125.0K | — | View → |
| Jun 10, 2026 | Jun 10 8:07 PM | JOHN L LAMATTINA | Proposed Sale | 4,519 | $250.88 | $1.1M | — | View → |
| Jun 10, 2026 | Jun 10 5:41 PM | Aryeh Jason | Proposed Sale | 5,000 | $249.35 | $1.2M | — | View → |
| Jun 1, 2026 | Jun 2 10:22 PM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $227.06 | $1.1M | 41,382(D) | View → |
| May 13, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 1,575 | $223.50 | $352.0K | 41,786(D) | View → |
| May 12, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 459 | $224.00 | $102.8K | 41,786(D) | View → |
| May 1, 2026 | May 15 1:08 AM | John W KozarichDirector | Sale | 467 | $231.80 | $108.3K | 41,786(D) | View → |
| May 13, 2026 | May 13 8:09 PM | JOHN KOZARICH | Proposed Sale | 1,575 | $223.50 | $352.0K | — | View → |
| May 12, 2026 | May 12 9:45 PM | JOHN KOZARICH | Proposed Sale | 459 | $224.00 | $102.8K | — | View → |
| May 1, 2026 | May 5 12:20 AM | Andrew ReardonCLO & Secretary | Sale | 5,000 | $231.31 | $1.2M | 41,382(D) | View → |
| May 1, 2026 | May 1 8:16 PM | KOZARICH JOHN W | Proposed Sale | 467 | $229.87 | $107.3K | — | View → |
Page 1 of 4
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | Mar 6 11:51 PM | Andrew ReardonCLO & Secretary | Option Exercise | 5,000 | $52.27 | 54,444(D) | View → |
| Mar 4, 2026 | Mar 6 11:49 PM | Octavio EspinozaChief Financial Officer | Option Exercise | 2,073 | $80.72 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 4:05 PM | Stephen L SabbaDirector | Option Exercise | 2,034 | $69.51 | 0(D) | View → |
← Previous
Page 2 of 2